CD79B and diffuse large B-cell lymphoma: Certain oncogenic changes in the immunotyrosine-based activation motif (ITAM) of CD79a and CD79b have been reported to occur in diffuse large B-cell lymphoma (DLBCL), which drive the segregation of the activated B-cell-like subtype [147,148,149].